article thumbnail

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Healthcare Innovation Consortium

Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded. We ensure that everything we do has the patient at the heart.

BioTech 60